About Bruce Beutel
Form D filings for Enveda Therapeutics in 2023 list Bruce Beutel as director.
Bruce Beutel first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Bruce Beutel in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bruce Beutel works with at each company, as listed on that company's latest Form D.
Enveda Therapeutics, Inc. · Form D, Mar 7, 2023
RS
Rohit Sharma
Director
ZD
Zavain Dar
Director
DW
Daniel Wee
Executive officer
SV
Shaquille Vayda
Director
VC
Viswa Colluru
Chief Executive Officer and director